Skip to main content

Table 4 Comparison of clinicopathological parameters of 97 locally advanced esophageal squamous cell carcinoma patients who received curative concurrent chemoradiotherapy according to VEGF day 28 level

From: The crucial role of blood VEGF kinetics in patients with locally advanced esophageal squamous cell carcinoma receiving curative concurrent chemoradiotherapy

Characteristics VEGF < 80 pg/mL group (N = 29) VEGF > 80 pg/mL group (N = 68) P value
Age
  < 60 years 21 (72%) 43 (63%) 0.38
  ≥ 60 years 8 (28%) 25 (37%)  
T status
 1 + 2 8 (28%) 7 (10%) 0.031a
 3 + 4 21 (72%) 61 (90%)  
N status
 0 + 1 9 (31%) 22 (32%) 0.90
 2 + 3 20 (69%) 46 (68%)  
Stage
 II + IIIA + IIIB 11 (38%) 21 (31%) 0.50
 IIIC 18 (62%) 47 (69%)  
Grade
 1 + 2 22 (76%) 49 (72%) 0.70
 3 7 (24%) 19 (28%)  
Location
 Upper 14 (48%) 26 (38%) 0.36
 Middle + Lower 15 (52%) 42 (62%)  
  1. VEGF vascular endothelial growth factor
  2. aStatistically significant